3Ando H, Furugori K, Shibata D, et al. Dual rennin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series. Hum Reprod, 2002,18(6):1 219-22.
4Delbaere A, Bergmann PJ, Gervy-Decoster C, et al. Increased angiotensin n in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Fertil Steril, 1997, 67(6):1 038-45.
5Delbaere A, Bergmann P J, Gervy-Decoster C, et al. Prorenin and active rennin concentrations in plasma and and ascites during severe ovarian hyperstimulations syndrome. Hum Reprod, 1997, 12(2):236-40.
6Delbaere A, Bergmann P J, Gervy-Decoster C, et al. Angiotensin Ⅱ immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Fertil Steril, 1994,62(4):731-7.
7Levin ER, Rosen GF, Cassidenti DI,, et al. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest, 1998,102:1 978-85.
8D'Ambrogio G, Fasciani A, Monti M, et al. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. Gynecol Endocrinol,1999, Oct, 13(5):311-5.
9Ludwig M, Jelkmann W, Bauer O, et al. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod, 1999,14(10):2 437-41.
10Enskog A, Nilsson L & Brannstrom M. Plasma levels of free vascular endothelial growth factor(165) (VEGF(165)) are not elevated during gonadotropin stimulation in m vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls. Eur J Obstet Gynecol Reprod Biol,2001,96(2):196-201.
